Feed OPCH
OP

Option Care Health

OPCH · NASDAQ

$24.30 -0.74% (-$0.18)
1M +3.45%
Market Cap $3.67B
P/E Ratio 17.51x
Div. Yield -
ROE 15.83%

Bulios Fair Price

$28.82

18.6% upside

Current Price

$24.3

Undervalued Fair Value Overvalued

According to Bulios Fair Price, OPCH is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
80 /100
Cheap
P/E 17.51x
EV/EBITDA 11.42x
P/FCF 10.58x
Growth
63 /100
Stable
EPS growth 15.23%
Rev. growth 12.72%
Book val. growth 1.46%
Profitability
32 /100
Weak
Gross margin 18.17%
Net margin 3.68%
FCF margin 6.09%
Quality
67 /100
Excellent
ROIC 9.59%
ROE 15.83%
Asset turnover 1.69x
Debt
55 /100
Moderate
Debt/Equity 1.01x
Current ratio 1.47x
Net debt/EBITDA 2.59x
Stability
79 /100
Stable
Beta 0.61x
Rev. volatility 3.56%
Profitable years 5

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about OPCH
Online

About the company

Option Care Health, Inc. is an American healthcare company specializing in providing home infusion therapy and other specialized healthcare services for patients who need treatment outside of hospital settings. Founded in 2009, its primary focus is on delivering infusion therapy to patients with chronic conditions, cancer, infections, and immune disorders. Option Care Health not only administers medications but also provides training to patients and their families, ensuring safe and effective use of therapies in the home environment. The company is one of the leading providers of home infusion care in the U.S., with a wide network of facilities and providers across the country.

Sector

Healthcare

Industry

Medical - Care Facilities

CEO

John C. Rademacher

Employees

7,397

Headquarters

Bannockburn

Upcoming events

29 OCT

Earnings

Upcoming earnings report

40d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.